H.R. 467 · 118th Congress (2023–2025)
HALT Fentanyl Act
This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
(The temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances into schedule I of the Controlled Substances Act expires on December 31, 2024.)
Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).
Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration.
The bill also makes several other changes to registration requirements for conducting research with controlled substances, including
- permitting a single registration for related research sites in certain circumstances,
- waiving the requirement for a new inspection in certain situations, and
- allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
Finally, the bill expresses the sense that Congress agrees with the interpretation of Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.
Show official title
To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
121 days after it was introduced
This is H.R. 467’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced4 months
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. H. Morgan Griffith (R-VA-9)
- Cosponsors
52 cosponsors
24 original · 28 later
52 R
- Rep. Rick W. Allen (R-GA-12)· Original · Jan 24, 2023
- Rep. Michael C. Burgess (R-TX-26)· Original · Jan 24, 2023
- Rep. Gus M. Bilirakis (R-FL-12)· Original · Jan 24, 2023
- Rep. Vern Buchanan (R-FL-16)· Original · Jan 24, 2023
- Rep. Larry Bucshon (R-IN-8)· Original · Jan 24, 2023
- Rep. Jim Banks (R-IN-3)· Original · Jan 24, 2023
- Rep. Troy Balderson (R-OH-12)· Original · Jan 24, 2023
- Rep. Kat Cammack (R-FL-3)· Original · Jan 24, 2023
- Rep. Earl L. "Buddy" Carter (R-GA-1)· Original · Jan 24, 2023
- Rep. John R. Curtis (R-UT-3)· Original · Jan 24, 2023
- Rep. Dan Crenshaw (R-TX-2)· Original · Jan 24, 2023
- Rep. Jeff Duncan (R-SC-3)· Original · Jan 24, 2023
- Rep. Neal P. Dunn (R-FL-2)· Original · Jan 24, 2023
- Rep. Scott Fitzgerald (R-WI-5)· Original · Jan 24, 2023
- Rep. Brett Guthrie (R-KY-2)· Original · Jan 24, 2023
- Rep. Richard Hudson (R-NC-9)· Original · Jan 24, 2023
- Rep. Diana Harshbarger (R-TN-1)· Original · Jan 24, 2023
- Rep. John Joyce (R-PA-13)· Original · Jan 24, 2023
- Rep. Robert E. Latta (R-OH-5)· Original · Jan 24, 2023
- Rep. Cathy McMorris Rodgers (R-WA-5)· Original · Jan 24, 2023
- Rep. Alexander X. Mooney (R-WV-2)· Original · Jan 24, 2023
- Rep. Mariannette Miller-Meeks (R-IA-1)· Original · Jan 24, 2023
- Rep. Gary J. Palmer (R-AL-6)· Original · Jan 24, 2023
- Rep. Tim Walberg (R-MI-5)· Original · Jan 24, 2023
- Rep. Kelly Armstrong (R-ND)· Later · Jan 25, 2023
- Rep. August Pfluger (R-TX-11)· Later · Jan 25, 2023
- Rep. Greg Pence (R-IN-6)· Later · Jan 25, 2023
- Rep. Jay Obernolte (R-CA-23)· Later · Feb 2, 2023
- Rep. Austin Scott (R-GA-8)· Later · Feb 2, 2023
- Rep. Chuck Edwards (R-NC-11)· Later · Feb 8, 2023
- Rep. Brad Finstad (R-MN-1)· Later · Feb 8, 2023
- Rep. Steve Womack (R-AR-3)· Later · Feb 8, 2023
- Rep. Jerry L. Carl (R-AL-1)· Later · Feb 14, 2023
- Rep. Debbie Lesko (R-AZ-8)· Later · Feb 17, 2023
- Rep. Mike Garcia (R-CA-27)· Later · Feb 27, 2023
- Rep. Ben Cline (R-VA-6)· Later · Mar 3, 2023
- Rep. Juan Ciscomani (R-AZ-6)· Later · Mar 3, 2023
- Rep. Stephanie I. Bice (R-OK-5)· Later · Mar 7, 2023
- Rep. John R. Carter (R-TX-31)· Later · Mar 7, 2023
- Rep. John R. Moolenaar (R-MI-2)· Later · Mar 17, 2023
- Rep. Aaron Bean (R-FL-4)· Later · Mar 28, 2023
- Rep. Harold Rogers (R-KY-5)· Later · Mar 28, 2023
- Rep. Daniel Meuser (R-PA-9)· Later · Apr 6, 2023
- Rep. Mike Bost (R-IL-12)· Later · Apr 13, 2023
- Rep. Andy Barr (R-KY-6)· Later · May 15, 2023
- Rep. Anthony D'Esposito (R-NY-4)· Later · May 15, 2023
- Rep. Jefferson Van Drew (R-NJ-2)· Later · May 15, 2023
- Rep. Tim Burchett (R-TN-2)· Later · May 17, 2023
- Rep. Lori Chavez-DeRemer (R-OR-5)· Later · May 17, 2023
- Rep. Nicholas A. Langworthy (R-NY-23)· Later · May 17, 2023
- Rep. Carol D. Miller (R-WV-1)· Later · May 17, 2023
- Rep. Bruce Westerman (R-AR-4)· Later · May 17, 2023
- Policy area
- Crime and Law Enforcement
- Subjects
- Administrative law and regulatory procedures
- Department of Justice
- Drug trafficking and controlled substances
- Licensing and registrations
- Research administration and funding
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
3 amendments
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
▸ 11 actions · Jan 24, 2023 – May 25, 2023
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Subcommittee markup session held
Subcommittee Consideration and Mark-up Session Held.
Sources
- Congress.gov action
- House committee actions
Forwarded by subcommittee
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 17 - 10 .
Sources
- Congress.gov action
- House committee actions
Subcommittee markup session held
Subcommittee Consideration and Mark-up Session Held.
Sources
- Congress.gov action
- House committee actions
Markup session held
Committee Consideration and Mark-up Session Held.
Sources
- Congress.gov action
- House committee actions
Ordered reported
Ordered to be Reported (Amended) by the Yeas and Nays: 27 - 19.
Sources
- Congress.gov action
- House committee actions
Committee discharged
Committee on the Judiciary discharged.
Sources
- Congress.gov action
- House floor actions
Reported by committee
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-67, Part I.
Sources
- Congress.gov action
- House floor actions
H.Amdt. 182, adopted
Offered by Rep. Max L. Miller (R-OH-7)
On agreeing to the Miller (OH) amendment (A001) Agreed to by voice vote.
Sources
- Congress.gov amendmentH.Amdt. 182
H.Amdt. 183, adopted
Offered by Rep. Cory Mills (R-FL-7)
On agreeing to the Mills amendment (A002) Agreed to by voice vote.
Sources
- Congress.gov amendmentH.Amdt. 183
H.Amdt. 184, failed
Offered by Rep. Brittany Pettersen (D-CO-7)
On agreeing to the Pettersen amendment (A003) Failed by recorded vote: 190 - 233 (Roll no. 236).
Sources
- Congress.gov amendmentH.Amdt. 184
Passed House
On passage Passed by the Yeas and Nays: 289 - 133 (Roll no. 237).
The House passed the bill.
Document: Engrossed in House
Sources
- Congress.gov action
- House Roll Call Vote 237
- House floor actions
- Latest
Referred to committee
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Sources
- Congress.gov action
- Senate
Expired
Passed House → Referred to Senate Judiciary → No further action before the 118th Congress ended.
Roll-call votes
Committees
- HouseEnergy and CommerceReferred Jan 24, 2023 · Markup Mar 24, 2023 · Reported May 17, 2023H. Rept. 118-67
Mar 23, 2023 · Markup
Mar 8, 2023 · Meeting
Feb 1, 2023 · Hearing
Floor record
i
Explicit consideration evidence: the measure’s bill-status citation matched a GovInfo title, headline, or first paragraph. Incidental mentions are not listed.
May 25, 2023 · House · Considered as unfinished businessCongressional Record H2602–H2605
Halt All Lethal Trafficking of Fentanyl Act
May 25, 2023 · House · Considered as unfinished businessCongressional Record H2605–H2606
Halt All Lethal Trafficking of Fentanyl Act
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House | ||
| Reported in House | ||
| Engrossed in House | ||
| Referred in Senate |
Titles (3)
HALT Fentanyl Act
Display title, Short title · Referred in Senate, Introduced in House, Reported in House, Engrossed in House
Halt All Lethal Trafficking of Fentanyl Act
Short title · Referred in Senate, Introduced in House, Reported in House, Engrossed in House
To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.
Official title · Introduced in House